Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT02831738 · ClinicalTrials.gov registry record · NA

Fiber Effects on Glycemic Index

A NA study, sponsored by Clinical Nutrition Research Center, Illinois Institute of Technology.

Completed
Registry status
NA
Development phase
20
Enrollment target

NCT02831738: Completed NA study, sponsored by Clinical Nutrition Research Center, Illinois Institute of Technology.

NCT02831738 is a NA study that has completed, run by Clinical Nutrition Research Center, Illinois Institute of Technology. The registered enrollment target is 20 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (99% lower). According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT02831738, a NA study, has completed, sponsored by Clinical Nutrition Research Center, Illinois Institute of Technology.

COMPLETED
Registry status
NA
Development phase
20 participants
Enrollment target

Study Summary

Primary outcome measure: Changes in plasma glucose concentration over a 3 hour postprandial visit after administration of polydextrose (12g) compared to 0 mg placebo. Secondary outcome measure: Changes in gastrointestinal tolerance and acute bowel changes in 3 days following treatment administration.

Primary Outcome

plasma glucose concentration over a 3 hour Postprandial Test day

Interventions

  • DIETARY_SUPPLEMENT Polydextrose
  • DIETARY_SUPPLEMENT Control Treatment

Trial Details

FieldValue
Enrollment Target 20 participants
Start Date 2016-07-02
Est. Completion 2016-10-25
Phase NA

What the finished NCT02831738 record still lists

NCT02831738 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 20 participants, a relatively small participant target, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (99% lower).

The record links to 0 conditions, and to 2 interventions - of which Polydextrose is the first listed.

NCT02831738 does not publish any study locations in the registry export this page uses.

Frequently Asked Questions

What is clinical trial NCT02831738 about?

NCT02831738 is a clinical study titled "Fiber Effects on Glycemic Index". Primary outcome measure: Changes in plasma glucose concentration over a 3 hour postprandial visit after administration of polydextrose (12g) compared to 0 mg placebo. Secondary outcome measure: Changes in gastrointestinal tolerance and acute bowel changes in 3 days following treatment administratio...

What is the current status of trial NCT02831738?

This trial is currently completed. It is a NA study. The enrollment target is 20 participants. The study started on 2016-07-02. Estimated completion is 2016-10-25.

What interventions are being tested in trial NCT02831738?

The interventions under investigation include: Polydextrose (DIETARY_SUPPLEMENT), Control Treatment (DIETARY_SUPPLEMENT).

Who is sponsoring clinical trial NCT02831738?

This trial is sponsored by Clinical Nutrition Research Center, Illinois Institute of Technology, which has 59 total clinical trials registered on ClinicalTrials.gov.

How this trial's enrollment target compares

Where NCT02831738's enrollment target sits among peer trials

20 1768th of 2000 higher than 140 of 2,000 other NA trials

participants (enrollment target), bucketed by value

Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.

Source ClinicalTrials.gov registry export · 2026-08-08

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT00573339 · 20 participants

    Cardiac Magnetic Resonance Imaging (MRI) Normal Reference Control Group Testing

  • NCT00692939 · 20 participants · Phase 1

    Autologous Stem Cell Transplantation for Crohn's Disease

  • NCT00967785 · 20 participants · Phase 1

    A Phase I Study of Mozobil in the Treatment of Patients With WHIMS

  • NCT01406691 · 20 participants · Phase 4

    Light Flashes to Treat Delayed Sleep Phase Disorder (DSPD)

Similar registry start date

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

  • NCT07125183 · started 2026-12 · Phase 2

    Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma

  • NCT07292298 · started 2026-11 · Phase 2

    Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates

  • NCT04263285 · started 2026-10 · NA

    Treatment of Depression Post-SCI

Source: ClinicalTrials.gov NCT02831738, the US trial registry maintained by the National Library of Medicine. NCT02831738 (small enrollment · none site footprint · completed) retrieved and formatted by PlainTrial, see methodology.